Intracranial Stents: A Global Strategic Business Report
San Jose, California (PRWEB) February 04, 2015
Follow us on LinkedIn – Stroke is one of the leading causes of morbidity and mortality in the world. The aging population represents a key demographic factor driving growth in the market, since people aged over 40 years are at a higher risk of developing cerebrovascular diseases. Aging societies in North America, Western Europe, and Japan are expected to bring in a considerable increase in demand for intracranial stenting procedures. In densely populated, developing countries like China and India, changing lifestyles, increasing stress levels, hypertension, rising obesity rates, increasing blood cholesterol and blood pressure levels, smoking, and hyperlipidemia are driving increased incidences of stroke.
Intracranial Stents have revolutionized the treatment of arterial blockages and clot retrieval in patients suffering from cerebral aneurysms, severe intracranial atherosclerotic disease (ICAD), intracranial stenosis, acute ischemic stroke and other diseases of the brain. These stenting systems have been successfully used in revascularization of the brain tissue by restoring normal blood flow to the brain. However, the global intracranial stents market was significantly challenged in the last two years, following the issuance of a warning by the FDA calling for limited use of stents, based on results of the ‘Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis’ [SAMMPRIS] trial in 2012.
As stated by the new market research report on Intracranial Stents, the United States represents the largest market worldwide, followed by Europe. With the US and European healthcare industry reaching saturation, developing regions are forecast to spearhead future growth, driven by rising incidence of stroke, increasing healthcare spending, and improving quality of healthcare services. An affluent consumer base, increasing access to healthcare services and facilities, high unmet medical needs, are factors driving the market in developing countries. Further, the high cost of medical treatment procedures in developed economies has fuelled the popularity of medical tourism. A large number of people seeking medical treatment are travelling to developing countries where the cost of medical procedures and therapies are relatively cheaper and more affordable. The rise of medical tourism for neurovascular surgeries is therefore expected to drive demand in the coming years.
Major players covered in the report include Admedes Schuessler GmbH, BALT Extrusion, Cardiatis SA, Codman & Shurtleff Inc., Covidien PLC, ITGI Medical Ltd., MicroPort Scientific Corporation, OBEX Medical, and Stryker Corporation, among others.
The research report titled "Intracranial Stents: A Global Strategic Business Report," announced by Global Industry Analysts Inc., provides a comprehensive review of the market, key market trends, growth drivers, product launches, mergers and acquisitions, and profiles of major and niche market participants. The report provides market estimates and projections in US$ for geographic markets including the United States, Europe, and Rest of World.
For more details about this comprehensive market research report, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.